Compass Therapeutics, Inc. Share Price OTC Markets
Stocks
CMPX
US20454B1044
Biotechnology & Medical Research
OTC Markets Traded|
Delayed
OTC Markets
19:59:57 03/11/2021 GMT
|
5-day change | 1st Jan Change | ||
| 3.550 USD | -10.80% |
|
+32.67% | - |
| Market Cap | 432M 372M 349M 319M 601M 41.31B 602M 4.14B 1.62B 20.85B 1.62B 1.59B 69.14B | P/E 2026 * |
-4.79x | P/E 2027 * | -4.34x |
|---|---|---|---|---|---|
| Enterprise Value | 282M 243M 228M 208M 392M 26.97B 393M 2.71B 1.06B 13.62B 1.06B 1.04B 45.15B | EV / Sales 2026 * |
-
| EV / Sales 2027 * | 13.4x |
| Free-Float |
87.55% | Yield 2026 * |
-
| Yield 2027 * | - |
Last Transcript : Compass Therapeutics, Inc.
| 1 day | -10.80% |
| Manager | Title | Age | Since |
|---|---|---|---|
Thomas Schuetz
CEO | Chief Executive Officer | 65 | 27/05/2024 |
Barry Shin
DFI | Director of Finance/CFO | 54 | 08/12/2024 |
Bing Gong
CTO | Chief Tech/Sci/R&D Officer | 50 | 31/12/2025 |
| Director | Title | Age | Since |
|---|---|---|---|
Thomas Schuetz
BRD | Director/Board Member | 65 | 31/12/2013 |
Phil Ferneau
BRD | Director/Board Member | 64 | 31/12/2014 |
Carl Gordon
CHM | Chairman | 61 | 31/12/2014 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -10.80% | +32.67% | - | - | 454M | |
| -1.59% | -3.35% | +64.49% | +98.69% | 70.64B | |
| -1.34% | -0.75% | +48.56% | +90.63% | 66.11B | |
| -8.37% | -12.43% | +0.14% | -15.42% | 27.98B | |
| -2.35% | -5.75% | -12.17% | +448.29% | 26.51B | |
| +0.30% | -0.69% | +63.18% | +11.93% | 26.44B | |
| -0.96% | +10.36% | +278.86% | +438.78% | 20.4B | |
| -0.51% | +0.23% | +33.71% | -18.02% | 20.17B | |
| -1.91% | -4.37% | +13.33% | +531.29% | 15.99B | |
| -1.47% | +0.68% | +43.67% | +145.49% | 13.69B | |
| Average | -2.90% | +0.19% | +59.31% | +192.41% | 31.99B | |
| Weighted average by Cap. | -1.99% | +0.11% | +56.60% | +152.15% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | - | 22.39M 19.3M 18.09M 16.52M 31.11M 2.14B 31.21M 215M 83.75M 1.08B 84.08M 82.25M 3.58B |
| Net income | -94.04M -81.04M -75.98M -69.36M -131M -8.99B -131M -901M -352M -4.54B -353M -345M -15.04B | -110M -94.64M -88.73M -81M -153M -10.5B -153M -1.05B -411M -5.3B -412M -403M -17.57B |
| Net Debt | -150M -129M -121M -111M -208M -14.34B -209M -1.44B -561M -7.24B -563M -551M -24B | -133M -115M -107M -98.09M -185M -12.71B -185M -1.27B -497M -6.42B -499M -488M -21.28B |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- CMPX Stock
- CMPX Stock
Select your edition
All financial news and data tailored to specific country editions
